₹16.88
▲ +0.18 +1.08%
17 Jul 2026
BSE Listed
GSM 0Venmax Drugs And Pharmace (531015)
Volume: 4,130Avg Vol 1W: 17,052Avg Vol 1M: 7,71652W Range:₹15.56₹36.96
Key Ratios
Checked just nowMarket Cap₹20 Cr
Current Price₹16.88
Previous Close₹16.7
High / Low (52w)₹36.96 / ₹15.56
Volume4,130
Avg Vol (1W)17,052
Avg Vol (1M)7,716
Stock P/E80.38
Book Value₹12.18
Dividend Yield0%
ROE175.83%
ROA123.46%
Revenue (TTM)—
Revenue Growth—
Profit Margin249.38%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.21
P/B1.39
Debt / Equity0.11
50 DMA₹20.98
200 DMA₹24.77
Day change+1.08%
SurveillanceGSM 0 (as of 2026-07-17)
Price Chart
₹16.88▼ 34.57% · 1Y
2025-07-172026-07-17
20-day avg volume: 8K shares
Pros
- Healthy return on equity of 175.8%.
- Company is almost debt-free.
- Revenue grew 837% YoY.
Cons
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 80.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | -0.46 | -0.45 | -0.52 | -0.31 | 3.52 | 0.43 | 0.12 | -0.02 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹5 Cr |
| Total Liabilities | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Equity | ₹-2 Cr | ₹-2 Cr | ₹-3 Cr | ₹-3 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹4 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹-2 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹0 Cr | ₹-2 Cr | ₹0 Cr | ₹0 Cr | ₹5 Cr |
| Free Cash Flow | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹-2 Cr |
Shareholding
Promoter 13.8% Institutions 0% Public 86.2%
Efficiency & Working Capital
ROCE1.9%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-03-31
Promoter13.8%
FII0%
DII0%
Institutions0%
Public86.2%
Promoter Pledge0%
No. of Shareholders6,802
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 23.1% | 23.1% | 23.1% | 23.1% | 23.1% | 23.1% | 23.1% | 23.1% | 23.1% | 23.1% | 15.1% | 13.8% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0% | 0% | 0% | 0% |
| Public | 76.7% | 76.7% | 76.7% | 76.7% | 76.7% | 76.7% | 76.7% | 76.7% | 76.9% | 76.9% | 84.9% | 86.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 6,250 | 6,250 | 6,252 | 6,251 | 6,252 | 6,291 | 6,657 | 6,756 | 6,729 | 6,764 | 6,815 | 6,802 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Venkat Narender Nuka | Shareholding of Promoter and Promoter Group | 10.6% | 9,26,775 |
| Manish Grover | Public Shareholding | 6.3% | 5,50,000 |
| Percy Homi Italia | Public Shareholding | 5.3% | 4,66,161 |
| Wca Services Private Limited | Public Shareholding | 4.6% | 4,03,333 |
| Mega Flex Plastics Limited | Public Shareholding | 3.4% | 3,00,000 |
| Dr Tadla Tirumal Rao | Public Shareholding | 3.1% | 2,69,900 |
| Shammi Khanna | Public Shareholding | 2.9% | 2,50,000 |
| Dwarka Prasad Gattani | Public Shareholding | 2.3% | 2,00,000 |
| J Muralidharan | Public Shareholding | 2.3% | 2,00,000 |
| White Saffron Grains Llp | Public Shareholding | 2.3% | 2,00,000 |
| Sampati Devi Jain | Public Shareholding | 2.3% | 2,00,000 |
| Vincent Alex D'mello | Public Shareholding | 1.7% | 1,50,000 |
| Channel Plastics Private Limited | Public Shareholding | 1.7% | 1,45,000 |
| Sankalp Sunil Wakkar | Public Shareholding | 1.4% | 1,25,000 |
| N Achuta Bai | Shareholding of Promoter and Promoter Group | 1.2% | 1,04,250 |
| Jai Prakash Singh | Public Shareholding | 1.2% | 1,02,104 |
| Asset Reconstruction Company (india) Ltd. | Public Shareholding | 1.1% | 1,00,000 |
| Durga Dairy Limited | Public Shareholding | 1.1% | 1,00,000 |
| Venu Madhava Kaparthy | Public Shareholding | 1.1% | 1,00,005 |
| Mirza Sajjad Baig | Public Shareholding | 1.1% | 1,00,005 |
| Kapish Jain | Public Shareholding | 1.1% | 1,00,000 |
| Bhaiya Ishan | Public Shareholding | 1.1% | 1,00,000 |
| I2 Pro Services Private Limited | Public Shareholding | 1.1% | 1,00,000 |
| R Jagadish Kumar | Public Shareholding | 1.1% | 1,00,000 |
| Deepak Tayal | Public Shareholding | 1.1% | 1,00,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Banda Usha | 0 | 0% | 2026-03-31 |
| Venkat Narender Nuka | 0 | 0% | 2026-03-31 |
| Naresh V | 0 | 0% | 2026-03-31 |
| Banda Shamrao | 0 | 0% | 2026-03-31 |
| Bhaskar Rao Kanakabandi | 0 | 0% | 2026-03-31 |
| Shernaz Omim Debara | 0 | 0% | 2026-03-31 |
| N Jyothi Kiran | 0 | 0% | 2026-03-31 |
| N Achuta Bai | 0 | 0% | 2026-03-31 |
| R Padmavatamma | 0 | 0% | 2026-03-31 |
| T Devasena | 0 | 0% | 2026-03-31 |
| N Nirmala | 0 | 0% | 2026-03-31 |
| K Kondanna | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sadhanala Venkata Rao | Whole-time Director | 2025 |
| Swapneswar Mishra | Non-Exec & Non-Independent Dir | 2025 |
| D. Rakesh Reddy | Non-Exec & Non-Independent Dir | 2025 |
| Mr Reddeppa Gundluru | Independent Non Exe. Director | 2025 |
| Dakshita Jain | Independent Non Exe. Director | 2025 |
| Priyanka Agarwal | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 22 | 5 | 5 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 |
Company Information
🌐 www.venmaxdrugs.com ↗
📍 Sy No 115 Brig Sayeed Road, Hanumanji Colony Old Bowenpall, Secunderabad, Telangana, 500009
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search